Status:
UNKNOWN
Ketum and Pain Tolerence
Lead Sponsor:
Universiti Sains Malaysia
Collaborating Sponsors:
Yale University
Conditions:
Pain
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The study aim is to evaluate potential analgesic properties of ketum using the cold pressor task.
Detailed Description
Participants in the proposed study will be individuals who report consuming ketum more than once a day, daily for the past 12 months. The study is a placebo-controlled, double-blind within-subject rep...
Eligibility Criteria
Inclusion
- Individuals who report drinking ketum decoction more than once a day, daily for the past 12 months.
- \-
Exclusion
- (1) tested positive for illicit drug use including morphine, cannabis, methamphetamine, amphetamine, methadone, benzodiazepine and ketamine; (2) have current or previous history of psychological or neurological problems (self-report); (3) have current or previous alcohol use history (self-report); (4) HIV infections; (5) history of chronic liver disease (e.g. cirrhosis, hepatitis A, B, C, etc.) 6) non-alcoholic fatty liver disease; (7) history of coronary heart disease and diabetes; (8) existing chronic pain condition and (9) history of psychiatric disorders. Exclusion criteria for female particiapns: (1) pregnancy, (2) nursing.
- \-
Key Trial Info
Start Date :
January 23 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03414099
Start Date
January 23 2018
End Date
December 30 2021
Last Update
April 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Drug Research, Univerisiti Sains Malaysia
George Town, Pulau Pinang, Malaysia, 11800